Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mahmoud M. Samaha"'
Publikováno v:
Antioxidants, Vol 11, Iss 4, p 691 (2022)
The current study aimed to evaluate the anti-diabetic effects of canagliflozin (CANA) and indapamide (INDA) and their impacts as adiponectin modulators in experimentally induced type 2 diabetes mellitus (T2DM). T2DM was associated with a significant
Externí odkaz:
https://doaj.org/article/a083816aa6ea424b8ec012902975967c
Publikováno v:
Chemico-biological interactions. 328
The present study was undertaken to assess the effect of imatinib mesylate; a tyrosine kinase inhibitor and a well-known anticancer with numerous medical benefits on blood sugar levels, insulin, and glucagon secretion in an experimental model of STZ-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ac19858070ffb3f69b18aa35bdc512
https://pubmed.ncbi.nlm.nih.gov/32710900
https://pubmed.ncbi.nlm.nih.gov/32710900
Publikováno v:
Environmental Toxicology and Pharmacology. 90:103806
The objective of the present study is to evaluate and compare the possible anti-diabetic effects of adipoRon and diacerein in type 2 diabetes mellitus (T2DM) rats. T2DM is marked by impaired oxidative, inflammatory and metabolic signaling. Indeed, T2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::791b863c0d4a8850bf23ede13f30a1ea
https://doi.org/10.1016/j.etap.2021.103806
https://doi.org/10.1016/j.etap.2021.103806
Publikováno v:
Environmental Toxicology and Pharmacology. 72:103238
Type 1 diabetes mellitus (T1DM) describes a complex group of metabolic disorders associated with elevated blood glucose levels and increased risks of complications development. Exploring new drug therapies would reduce the increased diabetes-associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ead6435867813f9dbc04083560be1963
https://doi.org/10.1016/j.etap.2019.103238
https://doi.org/10.1016/j.etap.2019.103238
Publikováno v:
European Journal of Pharmacology. 860:172569
Type 1 diabetes mellitus (DM) remains an intractable disease with a limited number of therapeutic options. Recently, some studies have reported the role of inflammation in DM-induced β-cell destruction. Nilotinib hydrochloride, a tyrosine kinase inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd493bb369d9f7ba4fb6689c5d65122
https://doi.org/10.1016/j.ejphar.2019.172569
https://doi.org/10.1016/j.ejphar.2019.172569